Chiba Facilities ASIA MANUFACTURING CAPACITY With state-of-the-art clinical and commercial manufacturing facilities across the United States, Europe and Asia, AGC Biologics has the capacity and flexibility to meet each customer’s individual manufacturing needs. Our manufacturing facilities are multi-process, engineered for unilateral flow and segregated to produce multiple products at different stages of manufacturing in multiple parts of the facility. This increases the flexibility and number of manufacturing solutions available to meet clients’ rigorous manufacturing and quality needs. Right. On Time. CHIBA FACILITIES Our multi-purpose, highly-efficient Chiba facility is compatible with diverse processes, with a core structure and gravity-based facility design that guarantees flexibility and high quality. This facility offers vast experience with cGMP manufacturing for a large number of projects ranging from E. coli to yeasts. Contact us: 10, Goikaigan, Ichihara City Chiba 290-8566 Japan Tel: +81 3 3218 5694 Email: contactus@agcbio.com Microbial Facility Equipment cGMP FERMENTATION MANUFACTURING 4500L Fermenter 150L Fermenter 30L Fermenter TECHNOLOGIES High Cell Density Fermentation Inclusion Body Recovery Refolding Endotoxin Removal Scale Up & Process Optimization Large Scale Fermentation and Purification Centrifugal Separation Homogenization Membrane Separation Chromatography Purification ABOUT CAPABILITIES RESOURCES FACILITIES NEWS & EVENTS LEGAL & COMPLIANCE CONTACT US Follow us on LinkedIn Follow us on Twitter Follow us on Facebook NEWS AGC Biologics Appoints Jean-Baptiste Agnus as Chief Business Officer AGC Biologics Expands pDNA and mRNA Manufacturing Capacity AGC Biologics Announces the Groundbreaking of its New Facility at its Copenhagen, Denmark Site AGC Biologics Appoints Tony Fraij as the new General Manager/Site Head of the Longmont, Colorado Site AGC Biologics Acquires Commercial Facility, Expanding Cell & Gene Therapy Global Service Offerings EVENTS Cell & Gene Meeting on the Mesa, October 12-14, 2021 AGC Biologics is Attending BIO Asia-Taiwan July 23-26, 2021 Presenting Our Biological and Cell & Gene Therapy Capabilities AGC Biologics is Attending ASGCT May 11-14, 2021 and Presenting Our Scalable LVV Production Process and Large-Scale AAV Manufacturing Development Data AGC Biologics is Attending Meeting on the Med, April 6-9, 2021 FACILITIES SEATTLE, WASHINGTON (Headquarters) BOULDER, COLORADO LONGMONT, COLORADO COPENHAGEN, DENMARK HEIDELBERG, GERMANY MILAN, ITALY CHIBA, JAPAN ©2021 AGC Biologics. All Rights Reserved. Website Privacy Policy